Mitochondrial involvement in psychiatric disorders

References

• Anderson S, Bankier AT, Barrel BG, de Bruijn MHL. Sequence and organization of the human mitochondrial genome. Nature. 1981; 290: 457–65
   PubMed Web of Science ®Google Scholar
• Kato T. The other, forgotten genome: mitochondrial DNA and mental disorders. Mol Psychiatry. 2001; 6: 625–33
   PubMed Web of Science ®Google Scholar
• Horton HR, Moran LA, Ochs RS, Rawn JD, Scrimgeour KG. Principles of Biochemistry. Neil Patterson Publishers, Englewood Cliffs, NJ 1993
   Google Scholar
• Moyes CD, Buck LT, Hochachka PW. Temperature effects on pH of mitochondria isolated from carp red muscle. Regulatory, integrative and comparative physiology. Am J Physiol. 1988; 254: 611–5
   Google Scholar
• Chinnery PF, Schon EA. Mitochondria. J Neurol Neurosurg Psychiatry. 2003; 74: 1188–99
   PubMedGoogle Scholar
• Shanske AL, Shanske S, DiMauro S. The other human genome. Arch Pediatr Adolesc Med. 2001; 155: 1210–6
   Google Scholar
• Orth M, Schapira AH. Mitochondria and degenerative disorders. Am J Med Genet. 2001; 106: 27–36
   PubMed Web of Science ®Google Scholar
• Johns DR. The other human genome: mitochondrial DNA and disease. Nat Med. 1996; 2: 1065–8
   PubMed Web of Science ®Google Scholar
• Shoffner JM, Wallace D. The metabolic and molecular bases of inherited disease7th ed. McGraw-Hill, New York 1995
   Google Scholar
• Fattal O, Budur K, Vaughan AJ, Franco K. Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics. 2006; 47: 1–7
   PubMed Web of Science ®Google Scholar
• Dröge W, Schipper HM. Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell. 2007; 6: 361–70
   PubMed Web of Science ®Google Scholar
• Schaitman C, Greenawalt JW. Enzymatic properties of the inner and outer membranes of rat liver mitochondria. J Cell Biol. 1968; 38: 158–75
   Google Scholar
• Smith D, Filipowicz C, McCauley R. Monoamine oxidase A and monoamine oxidase B activities are catalyzed by different proteins. Biochim Biophys Acta. 1985; 831: 1–7
   PubMedGoogle Scholar
• Krueger KE, Papdopoulos V. Mitochondrial benzodiazepine receptors and the regulation of steroid biosynthesis. Annu Rev Pharmacol Toxicol. 1992; 32: 211–37
   PubMed Web of Science ®Google Scholar
• Schwartz M, Vissing J. New patterns of inheritance in mitochondrial disease. Annu Rev Pharmacol Toxicol. 2003; 310: 247–51
   Google Scholar
• Gottesman II, Bertelsen A. Confirming unexpressed genotypes for schizophrenia. Risks in the offspring of Fischer's Danish identical and fraternal discordant twins. Arch Gen Psychiatry. 1991; 46: 867–72
   Google Scholar
• Goldstein JM, Faraone SV, Chen WJ, Tsuang MT. Gender and the familial risk for schizophrenia. Disentangling confounding factors. Schizophr Res. 1992; 7: 135–40
   Google Scholar
• Wolyniec PS, Pulver AE, McGrath JA, Tam D. Schizophrenia: gender and familial risk. J Psychiatr Res. 1992; 26: 17–27
   PubMed Web of Science ®Google Scholar
• Shimizu A, Kurachi M, Yamaguchi N, Torii H, Isaki K. Morbidity risk of schizophrenia to parents and siblings of schizophrenic patients. J Psychiatry Neurol. 1987; 41: 65–70
   Google Scholar
• McMahon FJ, Stine OC, Meyers DA, Simpson SG, DePaulo JR. Patterns of maternal transmission in bipolar affective disorder. Am J Hum Genet. 1995; 56: 1277–86
   PubMed Web of Science ®Google Scholar
• Doi N, Hoshi Y. Persistence problem in schizophrenia and mitochondrial DNA. Am J Med Genet B Neuropsychiatr Genet. 2007; 144B: 1–4
   Google Scholar
• DeLisi LE, Razi K, Stewart J, Relja M, Shields G, Smith AB, et al. No evidence for a parent-of-origin effect detected in the pattern of inheritance of schizophrenia. Biol Psychiatry. 2000; 48: 706–9
   Google Scholar
• Kornberg JR, Brown JL, Sadovnick AD, Remick RA, Keck PE, McElroy SL, et al. Evaluating the parent-of-origin effect in bipolar affective disorder. Is a more penetrant subtype transmitted paternally?. J Affect Disord. 2000; 59: 183–92
   PubMed Web of Science ®Google Scholar
• Wallace DC. Diseases of the mitochondrial DNA. Annu Rev Biochem. 1992; 61: 1175–212
   PubMed Web of Science ®Google Scholar
• Hudson G, Carelli V, Spruijt L, Gerards M, Mowbray C, Achilli A, et al. Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. Am J Hum Genet. 2007; 81: 228–33
   PubMed Web of Science ®Google Scholar
• Hao H, Bonilla E, Manfredi G, DiMauro S, Moraes CT. Segregation patterns of a novel mutation in the mitochondrial tRNA glutamic acid gene associated with myopathy and diabetes mellitus. Am J Hum Genet. 1995; 56: 1017–25
   PubMed Web of Science ®Google Scholar
• Di Fonzo A, Bordoni A, Crimi M, Sara G, Del Bo R, Bresolin N, et al. POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions. Hum Mutat. 2003; 22: 498–506
   Google Scholar
• Simon DK, Johns DR. Mitochondrial disorders: clinical and genetic features. Annu Rev Med. 1999; 50: 111–27
   PubMed Web of Science ®Google Scholar
• Xu F, Morin C, Mitchell G, Ackerly A, Robinson BH. The role of the LRPPRC (leucine-rich pentatricopeptide repeat cassette) gene in cytochrome oxidase assembly: mutation causes lowered levels of COX (cytochrome c oxidase) I and COX III mRNA. Biochem J. 2004; 382: 331–6
   Google Scholar
• Petrozzi L, Ricci G, Giglioli NJ, Siciliano G, Mancuso M. Mitochondria and neurodegeneration. Biosci Rep. 2007; 27: 87–104
   PubMed Web of Science ®Google Scholar
• Kalman B, Laitinen K, Komoly S. The involvement of mitochondria in the pathogenesis of multiple sclerosis. J Neuroimmunol. 2007; 188: 1–12
   PubMed Web of Science ®Google Scholar
• DiMauro S, Moraes CT. Mitochondrial encephalomyopathies. Arch Neurol. 1993; 50: 1197–208
   PubMedGoogle Scholar
• Oexle K, Zwirner A. Advanced telomere shortening in respiratory chain disorders. Hum Mol Genet. 1997; 6: 905–8
   PubMed Web of Science ®Google Scholar
• Prayson RA, Wang N. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) syndrome: an autopsy. Arch Pathol Lab Med. 1998; 122: 978–81
   PubMedGoogle Scholar
• Siciliano G, Tessa A, Petrini S, Mancuso M, Bruno C, Grieco GS, et al. Autosomal dominant external ophthalmoplegia and bipolar affective disorder associated with a mutation in theANT1 gene. Neuromuscul Disord. 2003; 13: 162–5
   PubMedGoogle Scholar
• Grover S, Padhy SK, Das CP, Vasishta RK, Sharan P, Chakrabarti S. Mania as a first presentation in mitochondrial myopathy. Psychiatry Clin Neurosci. 2006; 60: 774–5
   Google Scholar
• Kasahara T, Kubota M, Miyauchi T, Noda Y, Mouri A, Nabeshima T, et al. Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes. Mol Psychiatry. 2006; 11: 577–93
   PubMed Web of Science ®Google Scholar
• Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V, et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull. 2001; 55: 597–610
   PubMed Web of Science ®Google Scholar
• Kung L, Roberts RC. Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study. Synapse. 1999; 31: 67–75
   PubMed Web of Science ®Google Scholar
• Inuwa IM, Peet M, Williams MA. QSAR modeling and transmission electron microscopy stereology of altered mitochondrial ultrastructure of white blood cells in patients diagnosed as schizophrenia and treated with antipsychotic drugs. Biotech Histochem. 2005; 80: 133–7
   PubMed Web of Science ®Google Scholar
• James R, Adams RR, Christie S, Buchanan DJ, Porteous DJ, Millar JK. Disrupted in Schizophrenia 1 (DISC1) is multicompartmentalized protein that predominantly localizes to mitochondria. Mol Cell Neurosci. 2004; 26: 112–22
   PubMedGoogle Scholar
• Kvajo M, Dhilla A, Swor DE, Karayiorgou M, Gogos JA. Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function. Mol Psychiatry. 2007 Aug 7 [ Epub ahead of print].
   Google Scholar
• Rodrigues T, Santos AC, Pigoso AA, Mingatto FE, Uyemura SA, Curti C. Thrioridazine interacts with the membrane of mitochondria acquiring antioxidant activity toward apoptosis-potentially implicated mechanisms. Br J Pharmacol. 2002; 136: 136–42
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y. Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria?. Genes Cells. 1998; 3: 697–707
   PubMed Web of Science ®Google Scholar
• Saldoña M, Bonastre M, Aguilar E, Marin C. Differential nigral expression of Bcl-2 protein family in chronically haloperidol and clozapine-treated rats: role in neurotoxicity and stereotyped behavior. Exp Neurol. 2007; 203: 302–8
   Google Scholar
• Wei Z, Mousseau DD, Richardson JS, Dyck LE, Li XM. Atypical antipsychotics attenuate neurotoxicity of beta-amyloid (25–35) by modulating Bax and Bcl-X(1/s) expression and localization. J Neurosci Res. 2003; 74: 942–7
   PubMed Web of Science ®Google Scholar
• Dean CE. Antipsychotic-associated neuronal changes in the brain: Toxic, therapeutic, or irrelevant to the long-term outcome of schizophrenia?. Prog Neuropsychopharmacol Biol Psychiatry. 2006; 30: 174–89
   PubMed Web of Science ®Google Scholar
• Volz HP, Rzanny R, May S, Hegewald H, Preussler B, Hajek M, et al. 31P magnetic resonance spectroscopy in the dorsolateral prefrontal cortex of schizophrenics with a volume selective technique—preliminary findings. Biol Psychiatry. 1997; 41: 644–8
   PubMed Web of Science ®Google Scholar
• Kegeles LS, Humaran TJ, Mann JJ. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy. Biol Psychiatry. 1998; 44: 382–98
   PubMedGoogle Scholar
• Deicken RF, Fein G, Weiner MW. Abnormal frontal lobe phosphorous metabolism in bipolar disorder. Am J Psychiatry. 1995; 152: 915–8
   PubMedGoogle Scholar
• Hamakawa H, Kato T, Shioiri T, Inubushi T, Kato N. Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Psychol Med. 1999; 29: 639–44
   PubMed Web of Science ®Google Scholar
• MacDonald ML, Naydenov A, Chu M, Matzilevich D, Konradi C. Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disord. 2006; 8: 255–64
   PubMed Web of Science ®Google Scholar
• Prince JA, Harro J, Blennow K, Gottfries CG, Oreland L. Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics. Neuropsychopharmacology. 2000;22:284–92. doi: 10.1038/sj.mp.4002052.
   PubMed Web of Science ®Google Scholar
• Buchsbaum MS, Hazlett EA. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr Bull. 1998; 24: 343–64
   PubMed Web of Science ®Google Scholar
• Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatrica Scandinavica. 2000; 101: 11–20
   PubMed Web of Science ®Google Scholar
• Strakowski SM, DelBello MP, Adler C, Cecil KM, Sax KW. Neuroimaging in bipolar disorder. Bipolar Disord. 2000; 2: 148–64
   PubMed Web of Science ®Google Scholar
• Patel TB, Clark JB. Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem J. 1979; 184: 539–46
   Google Scholar
• Clark JB. N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci. 1998; 20: 271–6
   PubMed Web of Science ®Google Scholar
• Steen RG, Hamer RM, Lieberman JA. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology. 2005; 30: 1949–62
   PubMed Web of Science ®Google Scholar
• Yildiz-Yesiloglu A, Ankerst DP. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysicology: A systematic review of the in vivo proton magnetic resonance spectroscopy findings. Prog Neuropsychopharmacol Biol Psychiatry. 2006; 30: 969–95
   PubMed Web of Science ®Google Scholar
• Altar CA, Jurata LW, Charles V, Lemire A, Liu P, Bukhman Y, et al. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry. 2005; 58: 85–96
   PubMed Web of Science ®Google Scholar
• Iwamoto K, Bundo M, Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet. 2005; 14: 241–53
   PubMed Web of Science ®Google Scholar
• Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry. 2004; 61: 300–8
   PubMed Web of Science ®Google Scholar
• Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry. 2004; 9: 684–97
   PubMed Web of Science ®Google Scholar
• Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci. 2002; 22: 2718–29
   PubMed Web of Science ®Google Scholar
• Solokov B, Jiang L, Trivedi N, Aston C. Transcription profiling reveals mitochondrial, ubiquitin and signaling systems abnormalities in postmortem brains from subjects with a history of alcohol abuse or dependence. J Neurosci Res. 2003; 72: 756–67
   Google Scholar
• Vawter MP, Tomita H, Meng F, Bolstad B, Li J, Evans S, et al. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry. 2006; 11: 663–79
   Web of Science ®Google Scholar
• Mexal S, Berger R, Adams C, Ross R, Freedman R, Leonard S. Brain pH has a significant impact on human postmortem hippocampal gene expression profiles. Brain Res. 2006; 1106: 1–11
   PubMedGoogle Scholar
• Weis S, Llenos IC, Dulay JR, Elashoff M, Martinez-Murillo F, Miller CL. Quality control for microarray analysis of human brain samples: The impact of postmortem factors, RNA characteristics, and histopathology. J Neurosci Methods. 2007; 165: 198–209
   PubMedGoogle Scholar
• Hamakawa H, Murashita J, Yamada N, Inubushi T, Kato N, Kato T. Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry Clin Neurosci. 2004; 58: 82–8
   PubMed Web of Science ®Google Scholar
• Kato T, Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord. 2000; 2: 180–90
   PubMed Web of Science ®Google Scholar
• Jurata LW, Bukhman YV, Charles V, Capriglione F, Bullard J, Lemire AL, et al. Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures. J Neurosci Methods. 2004; 138: 173–88
   PubMed Web of Science ®Google Scholar
• Bezchlibnyk YB, Wang JF, McQueen GM, Young LT. Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex. J Neurochem. 2001; 79: 826–34
   PubMedGoogle Scholar
• Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A. 2001; 98: 4746–51
   PubMed Web of Science ®Google Scholar
• Vawter MP, Crook JM, Hyde TM, Kleinman JE, Weinberger DR, Becker KG, et al. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res. 2002; 58: 11–20
   PubMed Web of Science ®Google Scholar
• Aston C, Jiang L, Sokolov BP. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res. 2004; 77: 858–66
   PubMed Web of Science ®Google Scholar
• Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry. 2004; 9: 406–16
   PubMed Web of Science ®Google Scholar
• Sibille E, Arango V, Galfalvy HC, Pavlidis P, Erraji-Benchekroun L, Ellis SP, et al. Gene expression profiling of depression and suicide in human prefrontal cortex. Neuropsychopharmacology. 2004; 29: 351–61
   PubMed Web of Science ®Google Scholar
• Mexal S, Frank M, Berger R, Adams CE, Ross RG, Freedman R, et al. Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. Brain Res Mol Brain Res. 2005; 139: 317–32
   PubMedGoogle Scholar
• Arion D, Unger T, Lewis DA, Levitt P, Mirnics K. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry. 2007; 62: 711–21
   PubMed Web of Science ®Google Scholar
• Atz M, Walsh D, Cartagena P, Li J, Evans S, Choudary P, et al. Methodological considerations for gene expression profiling of human brain. J Neurosci Methods. 2007; 163: 295–309
   PubMed Web of Science ®Google Scholar
• Martorell L, Segues T, Folch G, Valero J, Joven J, Labad A, et al. New variants in the mitochondrial genomes of schizophrenic patients. Eur J Hum Genet. 2006; 14: 520–8
   Google Scholar
• Munakata K, Fujii K, Nanko S, Kunugi H, Kato T. Sequence and functional analyses of mtDNA in a maternally inherited family with bipolar disorder and depression. Mutat Res. 2007; 617: 119–24
   Google Scholar
• Kazuno AA, Munakata K, Mori K, Tanaka M, Nanko S, Kunugi H, et al. Mitochondrial DNA sequence analysis of patients with'atypical psychosis’. Psychiatry Clin Neurosci. 2005; 59: 497–503
   Google Scholar
• Kirk R, Furlong RA, Amos W, Cooper G, Rubinsztein JS, Walsh C, et al. Mitochondrial genetic analyses suggest selection against maternal lineages in bipolar affective disorder. Am J Hum Genet. 1999; 65: 508–18
   PubMed Web of Science ®Google Scholar
• Marchbanks RM, Ryan M, Day IN, Owen M, McGuffin P, Whatley SA. A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress. Schizophr Res. 2003; 65: 33–8
   PubMed Web of Science ®Google Scholar
• Munakata K, Iwamoto K, Bundo M, Kato T. Mitochondrial DNA 3243A > G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol Psychiatry. 2005; 57: 525–32
   Google Scholar
• Munakata K, Tanaka M, Mori K, Washizuka S, Yoneda M, Tajima O, et al. Mitochondrial DNA 3644T– > C mutation associated with bipolar disorder. Genomics. 2004; 84: 1041–50
   PubMedGoogle Scholar
• Kato C, Umekage T, Tochigi M, Otowa T, Hibino H, Ohtani T, et al. Mitochondrial DNA polymorphisms and extraversion. Am J Med Genet B Neuropsychiatr Genet. 2004; 128: 76–9
   Google Scholar
• Washizuka S, Ikeda A, Kato N, Kato T. Possible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorder. Int J Neuropsychopharmacol. 2003; 6: 421–4
   Google Scholar
• Wallace DC, Ye JH, Neckelmann SN, Singh G, Webster KA, Greenberg BD. Sequence analysis of cDNAs for the human and bovine ATP synthase beta subunit: mitochondrial DNA genes sustain seventeen times more mutations. Curr Genet. 1987; 12: 81–90
   PubMed Web of Science ®Google Scholar
• Kato T, Stine OC, McMahon FJ, Crowe RR. Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder. Biol Psychiatry. 1997; 42: 871–5
   PubMed Web of Science ®Google Scholar
• Sabunciyan S, Kirches E, Krause G, Bogerts B, Mawrin C, Llenos IC, et al. Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder. J Neural Transm. 2007; 114: 665–74
   PubMedGoogle Scholar
• Cavelier L, Jazin EE, Eriksson I, Prince J, Bave U, Oreland L, et al. Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics. 1995; 29: 217–24
   PubMed Web of Science ®Google Scholar
• Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC. Mitochondrial DNA deletions in human brain: regional variability and increase with advancing age. Nat Genet. 1992; 2: 324–9
   PubMed Web of Science ®Google Scholar
• Kakiuchi C, Ishiwata M, Kametani M, Nelson C, Iwamoto K, Kato T. Quantitative analysis of mitochondrial DNA deletions in the brains of patients with bipolar disorder and schizophrenia. Int J Neuropsychopharmacol. 2005; 8: 515–22
   PubMed Web of Science ®Google Scholar
• Liu CS, Tsai CS, Kuo CL, Chen HW, Lii CK, Ma YS, et al. Oxidative stress-related alteration of the copy number of mitochondrial DNA in human leukocytes. Free Radic Res. 2003; 37: 1307–17
   PubMed Web of Science ®Google Scholar
• Frahm T, Mohamed SA, Bruse P, Gemünd C, Oehmichen M, Meissner C. Lack of age-related increase of mitochondrial DNA amount in brain, skeletal muscle and human heart. Mech Ageing Dev. 2005; 126: 1192–200
   PubMed Web of Science ®Google Scholar
• Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, Khrapko K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet. 2006; 38: 518–20
   PubMed Web of Science ®Google Scholar
• Li JZ, Vawter MP, Walsh DM, Tomita H, Evans SJ, Choudary PV, et al. Systemic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet. 2004; 13: 609–16
   PubMed Web of Science ®Google Scholar
• Fattal O, Link J, Quinn K, Cohen BH, Franco K. Psychiatric comorbidity in 36 adults with mitochondrial cytopathies. CNS Spectr. 2007; 12: 429–38
   PubMed Web of Science ®Google Scholar
• Karry R, Klein E, Ben Shachar D. Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study. Biol Psychiatry. 2004; 55: 676–84
   PubMed Web of Science ®Google Scholar
• Dairaghi DJ, Shadel GS, Clayton DA. Human mitochondrial transcription factor A and promoter spacing integrity are required for transcription initiation. Biochim Biophys Acta. 1995; 1271: 127–34
   PubMedGoogle Scholar
• Bonawitz ND, Clayton DA, Shadel GS. Initiation and beyond: multiple functions of the human mitochondrial transcription machinery. Mol Cell. 2006; 24: 813–25
   PubMed Web of Science ®Google Scholar
• Ukai W, Ozawa H, Tateno M, Hashimoto E, Saito T. Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol. J Neural Transm. 2004; 111: 667–81
   PubMed Web of Science ®Google Scholar
• Lee HC, Li SH, Lin JC, Wu CC, Yeh DC, Wei YH. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res. 2004; 547: 71–8
   PubMed Web of Science ®Google Scholar